
Sideline Gold on Fe...


| Price and Volume | |
|---|---|
| Recent Price | 3.72 |
| 52 Week High | 4.49 |
| 52 Week Low | 1.72 |
| Avg. Daily Vol. (Mil) | 0.63 |
| Beta (3 year) | 3.67 |
| Share Related Items | |
| Mkt Cap (Mil) | 208.36 |
| Shares Out (Mil) | 56.01 |
| Float (Mil) | 40.66 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.10 |
| Current Ratio | 5.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 33.89 |
| Price/Book | 6.11 |
| Price/Cash Flow | -6.70 |
| Per Share Data | |
| Earnings | -0.63 |
| Sales | 0.11 |
| Book Value | 0.61 |
| Cash Flow | -0.55 |
| Business Summary | |
|---|---|
| Nanosphere, Inc., develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, which enables simple, low cost, and highly sensitive genomic and protein testing on a single platform. | |
| General Information | |
| 4088 Commercial Avenue
Northbrook, IL 60062 |
|
| www.nanosphere.us | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 151 | |
| CEO: Michael K. McGarrity | |
| Short Interest | |
| Current Month (Mil) | 1.35 |
| Previous Month (Mil) | 0.97 |
| Short Interest Ratio (Days) | 1.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -82.30 |
| Return on Investments | -97.00 |
| Profitability | |
| Gross Margin | 70.80 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |